Zobrazeno 11 - 20
of 9 018
pro vyhledávání: ''
Autor:
Giuseppe Lamberti, Elisa Andrini, Giambattista Siepe, Cristina Mosconi, Valentina Ambrosini, Claudio Ricci, Paola Valeria Marchese, Gianluca Ricco, Riccardo Casadei, Davide Campana
Publikováno v:
Cancer Medicine. 11:4204-4213
Background: After radical resection of a nonmetastatic Merkel cell carcinoma (M0 MCC), postoperative radiation therapy (RT) is recommended as it improves survival. However, the role of RT in specific subgroups of M0 MCC is unclear. We sought to ident
Publikováno v:
Cancer Cytopathology. 130:705-713
Pleomorphic liposarcoma (PLPS) is the least common but most aggressive of all forms of liposarcoma (LPS). Its diagnosis relies on the recognition of pleomorphic lipoblasts (PLBs), whose numbers vary considerably. Because few large fine-needle aspirat
Autor:
Yutaka, Shimazu, Makoto, Murata, Takeshi, Kondo, Yosuke, Minami, Takayoshi, Tachibana, Noriko, Doki, Naoyuki, Uchida, Yukiyasu, Ozawa, Shingo, Yano, Takahiro, Fukuda, Jun, Kato, Takahide, Ara, Testuya, Eto, Jun, Ishikawa, Hirohisa, Nakamae, Junji, Tanaka, Tatsuo, Ichinohe, Yoshiko, Atsuta, Tokiko, Nagamura-Inoue
Publikováno v:
Hematological Oncology. 40:442-456
The introduction of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) treatment has dramatically improved the prognosis of CML patients and reduced the number of patients receiving allogeneic stem cell transplantation (allo-SCT). Ho
Autor:
Grant R. Williams, Mustafa Al‐Obaidi, Christian Harmon, Chen Dai, Darryl Outlaw, Olumide Gbolahan, Moh’d Khushman, Kirsten A. Nyrop, Nikesha Gilmore, Smita Bhatia, Smith Giri
Publikováno v:
Cancer
Despite recent advances in cancer, racial disparities in treatment outcomes persist, and their mechanisms are still not fully understood. The objective of this study was to examine racial differences in frailty and geriatric assessment impairments in
Autor:
Tetsu Hayashida, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Akiko Matsumoto, Anna Kubota, Hiromitsu Jinno, Hiroaki Miyata, Yuko Kitagawa
Publikováno v:
Cancer Science. 113:1722-1730
Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient-reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility
Publikováno v:
Cancer Medicine. 11:3304-3311
The study was conducted to evaluate racial differences in referral and uptake of genetic counseling (GC) in a clinic-based population of women with breast cancer.Medical records of 150 breast cancer patients at the Karmanos Cancer Institute were revi
Autor:
Juan Vaz, Patrik Midlöv, Malin Sternby Eilard, Berne Eriksson, David Buchebner, Ulf Strömberg
Publikováno v:
International Journal of Cancer. 151:229-239
Contemporary European studies examining associations between socioeconomic status and hepatocellular carcinoma (HCC) incidence are scarce. We aimed to target population groups with a heavier burden of HCC by assessing associations of individual-level
Autor:
Paul E. Wakely
Publikováno v:
Cancer Cytopathology. 130:443-454
Mesenchymal neoplasms of the parotid gland (PG) and para-pharyngeal (PP) space are distinctly uncommon. Fine-needle aspiration (FNA) biopsy experience with nonlipomatous neoplasms from this site is reviewed.Cytopathology and surgical pathology files
Autor:
Steven Ades, Bhargavi Pulluri, Chris E. Holmes, Inder Lal, Santosh Kumar, Benjamin Littenberg
Publikováno v:
Cancer Medicine. 11:1817-1826
The relationship between metastatic colorectal cancer (mCRC) and venous thromboembolism (VTE) is poorly defined in the modern era. Our objective was to examine impact of putative risk factors including newer treatments and anti-angiogenic therapy on
Autor:
Masatoshi Kanayama, Taiji Kuwata, Masataka Mori, Yukiko Nemoto, Natsumasa Nishizawa, Rintaro Oyama, Hiroki Matsumiya, Akihiro Taira, Shinji Shinohara, Masaru Takenaka, Kazue Yoneda, Koji Kuroda, Takashi Ohnaga, Fumihiro Tanaka
Publikováno v:
Cancer Science. 113:1028-1037
Detecting rare circulating tumor cells (CTCs) in the bloodstream is extremely challenging. We had previously developed a novel polymeric microfluidic device, "CTC-chip," for capturing CTCs and have shown high capture efficiency in lung cancer cell li